FBP1: Difference between revisions
CSV import |
CSV import |
||
| Line 28: | Line 28: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 11:37, 17 March 2025
FBP1 or Fructose-1,6-bisphosphatase 1 is an enzyme that in humans is encoded by the FBP1 gene. It is a crucial enzyme involved in gluconeogenesis, the metabolic pathway that results in the generation of glucose from certain non-carbohydrate carbon substrates.
Function[edit]
FBP1 is a glycolytic enzyme that catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate and inorganic phosphate. This reaction is a key regulatory step in the gluconeogenic pathway. The enzyme is found in the cytosol and is not associated with any subcellular organelle or membrane.
Clinical significance[edit]
Mutations in the FBP1 gene are associated with fructose-1,6-bisphosphatase deficiency, a rare autosomal recessive disorder. This condition is characterized by episodic acute crises of lactic acidosis and ketosis, often triggered by fasting or infections. Long-term complications may include delayed physical development, intellectual disability, and failure to thrive.
Structure[edit]
The FBP1 enzyme is a homotetramer, meaning it is composed of four identical subunits. Each subunit has a molecular weight of approximately 37 kDa. The enzyme has a unique allosteric site for AMP, which inhibits the enzyme activity, and another for fructose 2,6-bisphosphate, which enhances the enzyme activity.
See also[edit]
References[edit]
<references />
